The centralreach health care company Tape William Blair to continue a sale

• Centralreach has operated the investment bank William Blair to weigh a potential sale, Bi learned.
• The company manufactures electronic health file software for autistic care.
• A person who has knowledge of efforts said Centralreach may request an assessment of more than a billion dollars.

The manufacturer of autistic care software Centralreach has explored a sale, learned Business Insider.

Centralreach hit the investment bank William Blair to continue a potential sale, according to people who know the efforts.

Founded in 2012, Centralreach sells electronic health file software to suppliers who deal with autism and intellectual disorders and related development. The company also builds tools fueled by AI in its platform to help suppliers automate tasks such as examining clinical notes.

Centralreach and William Blair did not respond to requests for comments for this story.

Centralreach, based in Fort Lauderdale, in Florida, has been publicly silent on its finances to date. It is supported by the investment capital company, Insight Partners, which has invested a sum not disclosed in Centralreach in 2018.

Two people knowing Centralreach’s efforts said the company has skyrocketed as a software manufacturer for autistic care. One of these people said CentralReach was about $ 75 million in profits before deductions such as taxes and interest.

This person said they expect Centralreach to seek an assessment north of $ 1 billion, based on current market standards.

A number of health care companies have sought to sell after a slow year for business combinations in 2024.

Investors and bankers told Business Insider in February that health companies that are profitable and can demonstrate stable income will be much more attractive to buyers, in particular investment capital buyers.

The manufacturer of medical practice technologies Modmed announced on Monday that it had sold majority participation in the company PE Clearlake Capital of Warburg Pincus, which invested for the first time in Modmed in 2017. The company did not disclose the terms of the acquisition, but the Financial Times declared the day before that the agreement evaluated Modmed at $ 5.3 billion.

Centralreach has also made several acquisitions in recent years, more recently purchased behavioral science technology, which has built a platform to measure and follow the effectiveness of autistic therapy in September. During its 13 years of history, Centralreach made 14 acquisitions.

Related stories

Centralreach said in a September press release that its technology is used by more than 175,000 health professionals worldwide.